Evidence map›Paper›PMID 35446849›Full record

ArticlePloS one2022

Reversible domain closure modulates GlnBP ligand binding affinity.

Qun Chen, Fang Li, Xiaobing Zuo, Jin Chen, Peiwu Qin, Chuhui Wang, Jin Xu, Danyu Yang, Baogang Xing, Ying Liu and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Qun ChenCenter of Precision Medicine and Healthcare, Tsinghua-Berkeley Shenzhen Institute, Shenzhen, Guangdong Province, China.
Fang LiCenter of Precision Medicine and Healthcare, Tsinghua-Berkeley Shenzhen Institute, Shenzhen, Guangdong Province, China.
Xiaobing ZuoX-ray Science Division, Argonne National Laboratory, Argonne, IL, United States of America.
Jin ChenInstitute of Chinese medical sciences, University of Macau, Macau, China.
Peiwu QinCenter of Precision Medicine and Healthcare, Tsinghua-Berkeley Shenzhen Institute, Shenzhen, Guangdong Province, China.
Chuhui WangCenter of Precision Medicine and Healthcare, Tsinghua-Berkeley Shenzhen Institute, Shenzhen, Guangdong Province, China.
Jin XuShenzhen Aier Eye Hospital, Futian District, Guangdong Province, China.
Danyu YangShenzhen Aier Eye Hospital, Futian District, Guangdong Province, China.
Baogang XingUniversity of Science and Technology Hospital, Shenzhen, Guangdong Province, China.
Ying LiuFood Inspection & Quarantine Center, Shenzhen Custom, Shenzhen, Guangdong, China.
Peng JiaFood Inspection & Quarantine Center, Shenzhen Custom, Shenzhen, Guangdong, China.
Linling LiShenzhen Maternity and Child Healthcare Hospital, Affiliated to Southern Medical University, Shenzhen, Guangdong, China.
Chengming YangUniversity of Science and Technology Hospital, Shenzhen, Guangdong Province, China.
Dongmei YuSchool of Mechanical, Electrical & Information Engineering, Shandong University, Weihai, Shandong Province, China.ORCID 0000-0002-2436-4744
Tsinghua–Berkeley Shenzhen Institute · CNShenzhen Academy of Inspection and Quarantine · CNArgonne National Laboratory · USShandong University · CNShenzhen Maternity and Child Healthcare Hospital · CNUniversity of Macau · MO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glutamine binding protein (GlnBP) is an Escherichia Coli periplasmic binding protein, which binds and carries glutamine to the inner membrane ATP-binding cassette (ABC) transporter. GlnBP binds the ligand with affinity around 0.1μM measured by isothermal titration calorimetry (ITC) and ligand binding stabilizes protein structure shown by its increase in thermodynamic stability. However, the molecular determinant of GlnBP ligand binding is not known. Electrostatic and hydrophobic interaction between GlnBP and glutamine are critical factors. We propose that the freedome of closure movement is also vital for ligand binding. In order to approve this hypothesis, we generate a series of mutants with different linker length that has different magnitude of domain closure. Mutants show different ligand binding affinity, which indicates that the propensity of domain closure determines the ligand binding affinity. Ligand binding triggers gradual ensemble conformational change. Structural changes upon ligand binding are monitored by combination of small angle x-ray scattering (SAXS) and NMR spectroscopy. Detailed structure characterization of GlnBP contributes to a better understanding of ligand binding and provides the structural basis for biosensor design.

Indexed as

Escherichia coliGlutamineLigandsModels, MolecularProtein BindingScattering, Small AngleX-Ray DiffractionGlutamineLigands

Identifiers

PMID35446849
PMCPMC9022810
OpenAlexW4224285004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.